Sight Sciences, Inc. balance sheet SGHT

Annual Quarterly

As of Sep 30, 2026, Sight Sciences, Inc. had total assets of $104.9 million and total liabilities of $55.8 million. Total assets were down 9.7% from a year earlier. Stockholders' equity was $49.1 million. It held $77.4 million in cash and investments against $48.2 million of total debt, net cash of $29.2 million. The current ratio, current assets divided by current liabilities, was 5.04.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the same quarter a year earlier.

Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Assets
Cash
77
-16.2%
80
-21.4%
85
-21.9%
92
-23.6%
92
-22.1%
102
-14.1%
109
-14.5%
120
-12.9%
Cash and investments
77
-16.2%
80
-21.4%
85
-21.9%
92
-23.6%
92
-22.1%
102
-14.1%
109
-14.5%
120
-12.9%
Receivables
13
+37.3%
11
+18.4%
11
+12.4%
10
-9.7%
10
-24.6%
10
-51.7%
9
-39.8%
11
-24.5%
Inventory
7
-18.6%
6
-8.4%
7
+20.7%
8
+22.8%
8
+31.1%
6
-8.4%
6
-15.5%
6
-19.4%
Total current assets
101
-10.7%
101
-15.1%
107
-16.1%
113
-19.3%
114
-19.1%
119
-18.4%
127
-16.6%
140
-14.2%
Property and equipment, net
2
+10.7%
2
+14.2%
2
+9.0%
2
+1.9%
2
+6.7%
1
-1.9%
1
-4.2%
2
-3.7%
Total assets
105
-9.7%
105
-14.0%
110
-15.4%
115
-19.3%
116
-19.0%
122
-18.5%
130
-16.6%
143
-14.3%
Liabilities and equity
Accounts payable
3
+59.7%
2
-8.6%
1
-46.3%
1
-20.6%
2
+34.3%
2
+8.0%
3
+66.0%
2
-2.3%
Total current liabilities
20
+70.2%
20
+71.7%
18
+49.8%
11
-28.7%
12
-14.3%
12
-10.2%
12
+3.7%
15
+26.2%
Total liabilities
56
+7.4%
52
+0.0%
56
+7.2%
51
-7.2%
52
+6.8%
52
+8.1%
52
+12.3%
55
+19.1%
Stockholders' equity
49
-23.6%
53
-24.5%
54
-30.6%
64
-26.9%
64
-32.3%
70
-31.1%
78
-28.9%
88
-27.2%
Debt
Debt due within a year
12
20
8
—
—
—
—
—
Long-term debt
35
-12.7%
31
-23.0%
37
-7.2%
40
+2.4%
40
+17.3%
40
+17.9%
40
+17.5%
39
+24.1%
Lease liabilities
1
+74.8%
1
+59.9%
1
+39.5%
0
-52.8%
1
-45.6%
1
-40.3%
1
-32.9%
1
-32.3%
Total debt
48
+18.4%
52
+28.4%
46
+12.6%
41
+1.0%
41
+15.3%
41
+15.8%
40
+15.6%
40
+14.0%
Net cash
29
-43.4%
28
-54.6%
39
-42.3%
51
-36.0%
52
-37.9%
61
-26.7%
68
-26.0%
80
-22.1%
Ratios
Current ratio
5.04x
4.95x
5.86x
10.22x
9.60x
10.01x
10.47x
9.04x
Debt to equity
0.98x
0.99x
0.85x
0.64x
0.63x
0.58x
0.52x
0.46x
Return on equity
-57.79%
-56.26%
-69.11%
-60.10%
-71.72%
-70.00%
-63.63%
-58.85%
Return on assets
-27.06%
-28.37%
-33.96%
-33.33%
-39.66%
-40.18%
-38.09%
-36.06%
Book value per share
0.89
0.97
1.00
1.20
1.23
1.35
1.51
1.72
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
SGHT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Menlo Park, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1531177

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.